Showing 5851-5860 of 21466 results for "".
- 3D Printing and Personalized Medicine: Ketoprofen Tablets as a Case Studyhttps://reachmd.com/news/3d-printing-and-personalized-medicine-ketoprofen-tablets-as-a-case-study/2484528/In a recent study, fused deposition modeling (FDM) 3D printing produced ketoprofen tablets that delivered both immediate‑release and sustained‑release profiles from a single manufacturing platform, supporting on‑demand, point‑of‑care p
- NIH Grants for Vitiligo Research Rise Over Time, Driven by Medical Schools and NIAMShttps://reachmd.com/news/nih-grants-for-vitiligo-research-rise-over-time-driven-by-medical-schools-and-niams/2484513/Funding trends National Institutes of Health (NIH) funding trends shows steady, long-term support for vitiligo research from 1985 through 2024, according to a new analysis. Using the NIH Research Portfolio Online Reporting To
- Advancing Melanoma Diagnostics: AI and Digital Pathology Synergyhttps://reachmd.com/news/advancing-melanoma-diagnostics-ai-and-digital-pathology-synergy/2484521/A recent MDPI review found that AI-enabled digital pathology is improving melanoma diagnostic accuracy and reshaping pathology workflows. Narrative syntheses summarize comparative perfor
- The Role of Sleep Consistency in Hypertension Managementhttps://reachmd.com/news/sleep-consistency-hypertension-management/2484525/An Oregon Institute of Occupational Health Sciences study found that maintaining consistent bedtimes produced measurable reductions in bot
- Allergan Aesthetics Celebrates Seventh Annual BOTOX® Cosmetic Dayhttps://reachmd.com/news/allergan-aesthetics-celebrates-seventh-annual-botox-cosmetic-day/2484512/Allergan Aesthetics, an AbbVie company, marks the seventh annual BOTOX® Cosmetic Day on Wednesday, November 19, 2025. The yearly celebration honors patients and providers who have contributed to the longevity and success of the injectable treatment, which remains the top-selling product in its ca
- Navigating Anesthesia Through CMS 2026 Fee Schedule Updateshttps://reachmd.com/news/navigating-anesthesia-through-cms-2026-fee-schedule-updates/2484510/CMS's 2026 Physician Fee Schedule finalizes structural and telehealth updates that will immediately affect anesthesia reven
- FDA Accepts sNDA for ZORYVE Cream 0.3% in Children Aged 2 to 5https://reachmd.com/news/fda-accepts-snda-for-zoryve-cream-03-in-children-ages-25/2484497/The US Food and Drug Administration (FDA) has accepted Arcutis Biotherapeutics’ supplemental New Drug Application (sNDA) seeking an expanded indication for ZORYVE® (roflumilast) cream 0.3% to include children ages 2 to 5 with plaque psoriasis.
- Predictive Power: Machine Learning in Colorectal Surgical Planninghttps://reachmd.com/news/predictive-power-machine-learning-in-colorectal-surgical-planning/2484490/A newly validated extreme gradient boosting (XGB) model improves preoperative prediction of omental metastasis in right-sided colon cancer and has immediate implications for surgical planning for patients at elevated risk. Investigators compared six machine-learning
- Pluri Launches Regenerative Aesthetics Subsidiary Cellav in Collaboration with Miss Universe Skincarehttps://reachmd.com/news/pluri-launches-regenerative-aesthetics-subsidiary-cellav-in-collaboration-with-miss-universe-skincare/2484496/Pluri Inc. has launched Cellav Health and Aesthetics Ltd., focused on science-based regenerative skincare. The company announced a strategic collaboration with Miss Universe Skincare to co-develop a new line of cell-based skincare products.
- Ultra-processed Food Consumption and Early-Onset Colorectal Cancer Riskhttps://reachmd.com/news/ultra-processed-food-consumption-and-early-onset-colorectal-cancer-risk/2484478/Mass General Brigham reports that high intake of ultra-processed foods is linked to a substantially higher risk of conventional colorectal adenomas in adults under